These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20606123)

  • 41. Cardiac biomarkers: past, present, and future.
    Adams JE; Miracle VA
    Am J Crit Care; 1998 Nov; 7(6):418-23; quiz 424-5. PubMed ID: 9805114
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Do we need even more new biomarkers?].
    Schnabel RB; Blankenberg S
    Dtsch Med Wochenschr; 2013 Mar; 138(13):662-4. PubMed ID: 23512370
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
    Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Predictors of acute coronary syndrome without ST segment elevation and risk stratification in the chest pain unit].
    Gabrielli LA; Castro PF; Verdejo HE; McNab PA; Llevaneras SA; Mardonez JM; Corbalán RL
    Rev Med Chil; 2008 Apr; 136(4):442-50. PubMed ID: 18769786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men.
    Ohba H; Takada H; Musha H; Nagashima J; Mori N; Awaya T; Omiya K; Murayama M
    Am Heart J; 2001 May; 141(5):751-8. PubMed ID: 11320362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. B-type natriuretic peptide predicts complexity and severity of the coronary lesions in patients with acute coronary syndromes.
    Conde D; Elissamburu P; Lalor N; Rodriguez L; Trivi M
    Am J Emerg Med; 2013 Aug; 31(8):1282. PubMed ID: 23759681
    [No Abstract]   [Full Text] [Related]  

  • 48. [Use of noninvasive cardiac imaging for the evaluation of patients with chest pain: its use improves diagnostic accuracy].
    Trambaiolo P
    G Ital Cardiol (Rome); 2014; 15(7-8):405-7. PubMed ID: 25174593
    [No Abstract]   [Full Text] [Related]  

  • 49. B-type natriuretic peptides: prognostic markers in stable coronary artery disease.
    Omland T
    Expert Rev Mol Diagn; 2008 Mar; 8(2):217-25. PubMed ID: 18366308
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes.
    Wiviott SD; de Lemos JA; Morrow DA
    Clin Chim Acta; 2004 Aug; 346(2):119-28. PubMed ID: 15256312
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain.
    Kwan G; Isakson SR; Beede J; Clopton P; Maisel AS; Fitzgerald RL
    J Am Coll Cardiol; 2007 Mar; 49(11):1186-92. PubMed ID: 17367663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The emerging role of highly sensitive troponin in the evaluation of acute coronary syndrome.
    Mohammed AA; Januzzi JL
    Compr Ther; 2009; 35(3-4):167-76. PubMed ID: 20043613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biomarkers for the prediction of major adverse cardiovascular events in patients with acute coronary syndrome.
    Zeng Q; Sun XN; Ma LH; Chen L; Wang Y; Chen C; Ye ZY; Wu ZH; Li YZ; Xu Y
    Anat Rec (Hoboken); 2010 Sep; 293(9):1512-8. PubMed ID: 20652944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac biomarkers in Takotsubo cardiomyopathy.
    Doyen D; Moceri P; Chiche O; Schouver E; Cerboni P; Chaussade C; Mansencal N; Ferrari E
    Int J Cardiol; 2014 Jul; 174(3):798-801. PubMed ID: 24794960
    [No Abstract]   [Full Text] [Related]  

  • 55. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
    Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department.
    Bassan R; Tura BR; Maisel AS
    Coron Artery Dis; 2009 Mar; 20(2):143-9. PubMed ID: 19293713
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G; Corrado E; Mulè MC; Augugliaro S; Cucchiara A; Novo G; Amoroso G; Assennato P; Hoffmann E; Vitale F; Novo S
    Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Abnormal troponin I levels during pregnancy without acute coronary syndrome and without hypertensive disorders.
    Patanè S; Marte F; Di Bella G; Davi' M
    Int J Cardiol; 2008 Aug; 128(2):e47-9. PubMed ID: 17544531
    [No Abstract]   [Full Text] [Related]  

  • 59. Brain natriuretic peptide (BNP) as a biomarker of myocardial ischemia-reperfusion injury in cardiac transplantation.
    McIlroy DR; Wallace S; Roubos N
    J Cardiothorac Vasc Anesth; 2010 Dec; 24(6):939-45. PubMed ID: 20655247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy.
    Klingenberg R; Zugck C; Becker R; Schellberg D; Heinze G; Kell R; Remppis A; Schoels W; Katus HA; Dengler TJ
    Heart; 2006 Sep; 92(9):1323-4. PubMed ID: 16908708
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.